ARTICLE | Clinical News

LuViva Advanced Cervical Scan: Postmarketing study started

September 8, 2014 7:00 AM UTC

Guided Therapeutics began a blinded, U.S. and Peruvian postmarketing trial to compare LuViva Advanced Cervical Scan vs. visual examination with acetic acid, cytology, HPV, colposcopy and biopsy in 600-800 women.

LuViva is approved in the EU, Mexico, Canada, Turkey, South Asia, Middle East and sub-Saharan Africa for use in women identified as being at risk for cervical cancer by abnormal cytology, HPV test or previous cervical disease. ...